1. Home
  2. PGEN vs ACCD Comparison

PGEN vs ACCD Comparison

Compare PGEN & ACCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGEN
  • ACCD
  • Stock Information
  • Founded
  • PGEN 1998
  • ACCD 2007
  • Country
  • PGEN United States
  • ACCD United States
  • Employees
  • PGEN N/A
  • ACCD N/A
  • Industry
  • PGEN Biotechnology: Pharmaceutical Preparations
  • ACCD Business Services
  • Sector
  • PGEN Health Care
  • ACCD Consumer Discretionary
  • Exchange
  • PGEN Nasdaq
  • ACCD Nasdaq
  • Market Cap
  • PGEN 292.6M
  • ACCD 281.1M
  • IPO Year
  • PGEN N/A
  • ACCD 2020
  • Fundamental
  • Price
  • PGEN $0.90
  • ACCD $3.71
  • Analyst Decision
  • PGEN Buy
  • ACCD Buy
  • Analyst Count
  • PGEN 5
  • ACCD 12
  • Target Price
  • PGEN $7.00
  • ACCD $9.04
  • AVG Volume (30 Days)
  • PGEN 858.0K
  • ACCD 1.3M
  • Earning Date
  • PGEN 11-14-2024
  • ACCD 01-06-2025
  • Dividend Yield
  • PGEN N/A
  • ACCD N/A
  • EPS Growth
  • PGEN N/A
  • ACCD N/A
  • EPS
  • PGEN N/A
  • ACCD N/A
  • Revenue
  • PGEN $3,963,000.00
  • ACCD $441,028,000.00
  • Revenue This Year
  • PGEN N/A
  • ACCD $15.56
  • Revenue Next Year
  • PGEN $211.35
  • ACCD $11.76
  • P/E Ratio
  • PGEN N/A
  • ACCD N/A
  • Revenue Growth
  • PGEN N/A
  • ACCD 16.04
  • 52 Week Low
  • PGEN $0.77
  • ACCD $3.08
  • 52 Week High
  • PGEN $1.93
  • ACCD $15.36
  • Technical
  • Relative Strength Index (RSI)
  • PGEN 52.02
  • ACCD 57.22
  • Support Level
  • PGEN $0.77
  • ACCD $3.30
  • Resistance Level
  • PGEN $1.05
  • ACCD $3.80
  • Average True Range (ATR)
  • PGEN 0.07
  • ACCD 0.19
  • MACD
  • PGEN -0.00
  • ACCD 0.04
  • Stochastic Oscillator
  • PGEN 47.46
  • ACCD 87.50

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

About ACCD Accolade Inc.

Accolade Inc offers technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. The company's platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Care Advocates and clinicians, including registered nurses, physician medical directors, pharmacists, primary care physicians, and other professionals to provide advocacy, medical opinion, and virtual primary care services.

Share on Social Networks: